Stocks-RGEN-Repligen Corp

RGEN Repligen Corp

160.55 -1.17 (-0.72%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade

Repligen Corp price

0% Past Week
Created with Highcharts 4.2.7 /Highstock 4.2.7
Market Cap
8.95B
Day’s Range
159.72
-
163.00
52W Range
134.51
-
224.89
Volume (3M)
560.61K
Price-Earnings Ratio
66.44
Revenue
729.33M

Repligen Corp Latest News

View All
Pinned Post
Genome Engineering
AstraZeneca's Alexion completes purchase and licence agreement from Pfizer 👉 Alexion, $AZN.L (AstraZeneca) Rare Disease, has completed a definitive purchase and licence agreement for a portfolio of preclinical rare disease gene therapy programmes and enabling technologies from $PFE (Pfizer) . 👉... Show More
Top Discussions

About Repligen Corp

Repligen Corp is an American bioprocessing company engaged in the development, production, and commercialisation of high-value, innovative products used in the process of manufacturing biologic drugs. The firm supplies a range of customers worldwide, including life sciences companies, global biopharmaceutical firms, and contract manufacturers. The firm was founded in 1981 and is based in Boston, Massachusetts. In addition to operating manufacturing sites in Massachusetts, Repligen Corp also owns sites in California, Sweden, and Germany. The company has contributed to various important medical advances including products for cell culture intensification, tangential flow depth filtration, pre-packed columns, single-use cassettes, and integrated tangential flow filtration (TFF) systems. Repligen Corp is a leading manufacturer of Protein A affinity ligands, which are a critical component of Protein A resins used in the manufacture of monoclonal antibody therapeutics. The firm’s products are marketed to customers across the globe through a direct commercial organisation operating in the United States, Europe, and Asia. Repligen Corp also works with strategic partners and distributors in select markets. The firm trades on the NASDAQ, where it is publicly listed under the stock ticker RGEN. Use your eToro watchlist to monitor the RGEN price chart and receive real-time news updates and information on Repligen Corp.
Tony J. Hunt, MBA
CEO
2K
Employees
1981
Founded
Waltham, Massachusetts, US
HQ
Show More

Upcoming Events

31
OCT
REPORTS
Repligen Corp Q3 2023 earnings report is expected to be released before market open

ESG: A New Source of Insight

Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
58
High
Industry 
Avg. 47 
65
Environment
68
Social
46
Governance

Business Involvement Flags

People Also Bought